Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Cisapride (R 51619): Deep Phenotypic Profiling in Cardiot...
2025-10-09
Explore how Cisapride (R 51619), a nonselective 5-HT4 receptor agonist and hERG potassium channel inhibitor, is revolutionizing cardiac electrophysiology research through integration with deep learning phenotypic profiling. Discover novel insights into predictive cardiotoxicity screening and advanced in vitro methodologies.
-
Leucovorin Calcium: Advancing Methotrexate Rescue in Canc...
2025-10-08
Leucovorin Calcium, a potent folate analog, is revolutionizing methotrexate rescue and antifolate drug resistance research in complex tumor models. Its integration into assembloid and organoid systems enhances protection from methotrexate-induced growth suppression while illuminating new avenues for personalized cancer therapies.
-
Calpeptin and the Calpain Pathway: Strategic Horizons for...
2025-10-07
This thought-leadership article explores the transformative role of Calpeptin, a highly potent calpain inhibitor, in advancing translational research on fibrosis, inflammation, and cancer. Integrating mechanistic insights, experimental validation, and strategic guidance, the piece provides a differentiated, systems-level perspective on leveraging calpain inhibition for disease modeling, target validation, and therapeutic innovation. With actionable recommendations and nuanced analysis of recent studies, this article goes beyond standard product discussions to chart new directions for investigators in pulmonary fibrosis and beyond.
-
Acridine Orange Hydrochloride: Illuminating the Nexus of ...
2025-10-06
This thought-leadership article provides a mechanistic deep dive and strategic roadmap for translational researchers leveraging Acridine Orange hydrochloride. It explores the dye’s dual-fluorescence capabilities for nucleic acid staining within the context of cytoskeleton-driven mechanotransduction and autophagy, integrating recent peer-reviewed findings and benchmarking against the competitive landscape. The discussion extends beyond conventional protocols, offering practical guidance for bridging basic discoveries to clinical impact.
-
Translational Breakthroughs in Oncology: Leveraging High-...
2025-10-05
Explore how the L1023 Anti-Cancer Compound Library empowers translational researchers to accelerate biomarker-guided drug discovery, with mechanistic insights into new molecular targets like PLAC1. This article interweaves the latest experimental evidence with strategic advice on deploying high-throughput screening to redefine therapeutic paradigms in precision oncology.
-
DAPI (hydrochloride): Illuminating Tumor Microenvironment...
2025-10-04
Explore how DAPI (hydrochloride), a leading fluorescent DNA stain, enables advanced analysis of immune and myeloid cell dynamics within the tumor microenvironment. This article reveals unique strategies for integrating DAPI in cancer immunology, distinguishing itself from organoid-focused applications.
-
7-Ethyl-10-hydroxycamptothecin: Optimizing Colon Cancer A...
2025-10-03
Leverage 7-Ethyl-10-hydroxycamptothecin as a dual-action DNA topoisomerase I inhibitor and apoptosis inducer in advanced colon cancer research. This guide translates mechanistic insights and recent FUBP1 findings into practical workflows, troubleshooting advice, and actionable protocol enhancements for in vitro metastatic cancer models.
-
Dexamethasone (DHAP) as a Next-Generation Translational T...
2025-10-02
Explore how Dexamethasone (DHAP) is revolutionizing neuroinflammation research, immunology, and stem cell science. This thought-leadership piece uncovers the molecular rationale, evidentiary support, and strategic guidance for translational researchers seeking to harness the full potential of this advanced glucocorticoid anti-inflammatory reagent.
-
Sulfo-NHS-SS-Biotin Kit: Advancing Selective Cell Surface...
2025-10-01
Explore how the Sulfo-NHS-SS-Biotin Kit enables precise, reversible cell surface protein labeling for advanced proteomics. Learn about its unique mechanism, advantages over traditional biotinylation reagents, and its pivotal role in deconstructing cell surface nanodomains with unparalleled specificity.
-
Proteostasis in Translation: Harnessing Bortezomib (PS-34...
2025-09-30
Translational researchers face the dual challenge of dissecting complex proteasome-regulated cellular processes and translating these insights into tangible advances in cancer therapy. This article bridges mechanistic understanding with strategic guidance, exploring how Bortezomib (PS-341) serves as a powerful, reversible 20S proteasome inhibitor for both fundamental and translational research. By integrating emerging insights from mitochondrial proteostasis and apoptosis signaling, we chart a path for leveraging Bortezomib to interrogate—and ultimately target—dysregulated proteostasis in oncology.
-
SP600125: Unraveling JNK Inhibition for Precision Disease...
2025-09-29
Explore how SP600125, a potent JNK inhibitor, enables precision modulation of the JNK signaling pathway in advanced disease models. This article provides a unique, mechanistic analysis of ATP-competitive JNK inhibition and its translational impact in apoptosis, inflammation, and cancer research.
-
Bortezomib (PS-341): Unraveling Proteasome Inhibition and...
2025-09-28
Explore how Bortezomib (PS-341), a reversible proteasome inhibitor, uniquely advances cancer research by linking 20S proteasome inhibition with mitochondrial proteostasis and metabolic regulation. Discover new insights into apoptosis signaling and experimental applications, setting this article apart from prior reviews.
-
Diclofenac as a Quantitative Probe in Intestinal Organoid...
2025-09-27
Explore how Diclofenac, a leading non-selective COX inhibitor, enables quantitative pharmacokinetic and mechanistic inflammation pathway studies in hiPSC-derived intestinal organoids. This article unveils new strategies for precise prostaglandin synthesis inhibition and advanced anti-inflammatory drug research.
-
Streptavidin-FITC: Next-Gen Fluorescent Probes for Nuclei...
2025-09-26
Explore how Streptavidin-FITC enables advanced fluorescent detection of biotinylated molecules and nucleic acids. This in-depth guide reveals mechanistic insights, unique assay strategies, and future directions for high-sensitivity research using fluorescein isothiocyanate conjugated streptavidin.
-
Sulfo-NHS-SS-Biotin: Advancing Surface Proteome Degradati...
2025-09-25
15955 records 23/1064 page Previous Next First page 上5页 2122232425 下5页 Last page